# A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®

> **NCT03551873** · — · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Chronic Idiopathic Constipation

## Interventions

- **DRUG:** Plecanatide

## Key facts

- **NCT ID:** NCT03551873
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-21
- **Primary completion:** 2018-12-14
- **Final completion:** 2018-12-14
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03551873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03551873, "A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT03551873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
